Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Meara, J.
Right arrow Articles by Hobson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meara, J.
Right arrow Articles by Hobson, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Age and Ageing, Vol 28, 35-38, Copyright © 1999 by British Geriatrics Society


ARTICLES

Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson's disease and their carers in the community

J Meara, E Mitchelmore and P Hobson
University Department of Geriatric Medicine, Glan Clwyd Hospital, Rhyl, North Wales, UK.

OBJECTIVES: To assess the level of depressive symptomatology in a community based group of patients with Parkinson's disease (PD) and their carers and to investigate the patient characteristics that might predict carer distress. METHODS: The GDS-15 geriatric depression scale was used to measure self-rated depressive symptoms in a group of 132 subjects with clinically probable PD randomly selected from a community- based disease register. Disease severity was assessed by the Webster scale and cognitive function by the CAMCOG test. Carers of the patients, who in this study were all spouses, were also asked to complete the GDS-15. RESULTS: A total of 64% of our group of patients and 34% of carers scored within the 'depressed' range on the GDS-15. Patients with high levels of depressive symptoms tended to have more severe disease, disease of longer duration and more impaired cognitive function. The GDS score of the carer was best predicted by the GDS score of the patient being cared for. Less than 10% of patients and carers were being treated with antidepressant medication. CONCLUSIONS: This community-based study confirms the high level of depressive symptoms in PD suggested by hospital- and clinic-based studies. Depression in patients appears to be related to disease severity and cognitive impairment. An important determinant of carer distress and mood disorder, as reflected by the GDS score, appears to be the level of depression expressed by the patient being cared for. Despite high levels of depressive symptoms in both patients and carers, very few subjects were in receipt of antidepressant drug therapy.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
S. A. Parashos, C. J. Swearingen, K. M. Biglan, I. Bodis-Wollner, G. S. Liang, G. W. Ross, B. C. Tilley, L. M. Shulman, and for the NET-PD Investigators
Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience
Arch Neurol, September 1, 2009; 66(9): 1099 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Arch Clin NeuropsycholHome page
J. N. Hook, M. J. Marquine, and J. B. Hoelzle
Repeatable Battery for the Assessment of Neuropsychological Status Effort Index performance in a medically ill geriatric sample
Arch Clin Neuropsychol, June 23, 2009; (2009) acp026v1.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
Parkinson Study Group CALM Cohort Investigators
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Arch Neurol, May 1, 2009; 66(5): 563 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J-P Taylor, E N Rowan, D Lett, J T O'Brien, I G McKeith, and D J Burn
Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype
J. Neurol. Neurosurg. Psychiatry, December 1, 2008; 79(12): 1318 - 1323.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
G. Arabia, B. R. Grossardt, Y. E. Geda, J. M. Carlin, J. H. Bower, J. E. Ahlskog, D. M. Maraganore, and W. A. Rocca
Increased Risk of Depressive and Anxiety Disorders in Relatives of Patients With Parkinson Disease
Arch Gen Psychiatry, December 1, 2007; 64(12): 1385 - 1392.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
The NINDS NET-PD Investigators
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
Neurology, January 2, 2007; 68(1): 20 - 28.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Y. Uc, M. Rizzo, S. W. Anderson, S. Qian, R. L. Rodnitzky, and J. D. Dawson
Visual dysfunction in Parkinson disease without dementia
Neurology, December 27, 2005; 65(12): 1907 - 1913.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F S Ertan, T Ertan, G Kiziltan, and H Uygucgil
Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1445 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
L. L. Davis, M. Weaver, E. Zamrini, A. Stevens, D.-H. Kang, and C. R. Parker Jr
Biopsychological Markers of Distress in Informal Caregivers
Biol Res Nurs, October 1, 2004; 6(2): 90 - 99.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.